Stay updated on APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Sign up to get notified when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Removed the 403 error page elements (doctype, meta tags and Home link), resulting in the study details page becoming accessible again.
    Difference
    0.5%
    Check dated 2026-09-28T16:30:40.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The Study Record page is now rendering a 403 Forbidden error instead of the usual study details, signaling an access issue. The UI reflects an error state rather than updated or added study content.
    Difference
    18%
    Check dated 2026-09-21T20:20:34.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    34 days ago
    Change Detected
    Summary
    The page shows Revision: v3.6.6, replacing Revision: v3.6.5. This indicates a minor update to the page's version metadata rather than substantive changes to study details.
    Difference
    0.1%
    Check dated 2026-08-31T17:00:23.000Z thumbnail image
  5. Check
    56 days ago
    Change Detected
    Summary
    The study page now displays an error/unavailable message, replacing the usual study details and navigation.
    Difference
    17%
    Check dated 2026-08-10T10:40:41.000Z thumbnail image
  6. Check
    70 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4. This indicates a small internal update to the Study Details page.
    Difference
    0.0%
    Check dated 2026-07-27T06:16:54.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.3, replacing the previous Revision: v3.6.2. This indicates a page update or correction on ClinicalTrials.gov but does not modify the underlying study data or eligibility criteria.
    Difference
    0.0%
    Check dated 2026-07-05T04:38:22.000Z thumbnail image

Stay in the know with updates to APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.